FDA Clears Generic Rival To High-Priced EpiPenThe Food and Drug Administration on Thursday cleared Teva Pharmaceutical Industries to start selling generic versions EpiPen and EpiPen Jr., years after the Israeli drugmaker requested it.
Interior Dept. Spending $139K To Upgrade Doors In Sec. Zinke's OfficeThe Interior Department is spending nearly $139,000 to upgrade three sets of double doors in the office of Secretary Ryan Zinke.
Americans Say Congress Is Listening To All The Wrong PeopleIn red, blue or purple states, in middle America or on the coasts, most Americans loathe the nation's legislature. One big reason: Most think lawmakers are listening to all the wrong people
President Trump To Declare Opioid Public Health EmergencyPresident Donald Trump will direct his Department of Health and Human Services to declare the opioid crisis a nationwide public health emergency under the Public Health Service Act.
Facebook To Turn Over Russia-Linked Ads Social media giant Facebook is expected to provide Congress on Monday with more than 3,000 ads that ran around the time of the 2016 presidential election and are linked to a Russian ad agency.
Report: Former Equifax CEO To Get $90 Mil Severance Following Data BreachEquifax CEO Richard Smith will reportedly collect a $90 million severance package after stepping down from his position following the company's massive data breach that affected up to 143 million U.S. customers.
Facebook To Release Russia Ads, Beef Up Election 'Integrity'Bowing to pressure from lawmakers and the public, the company said it will provide the contents of 3,000 ads bought by a Russian agency to congressional investigators, while also pledging to make political advertising on its platform more "transparent."
More Companies Reducing Size Of Products, Price Stays The SameYou might not notice it right away. But more companies are reducing the size of their products, while the prices stay the same.
CVS Puts Out Generic Competitor To EpiPen At A 6th The PriceCVS is now selling a rival generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated because of its soaring cost.
Drugmakers Set To Gain As Taxpayers Foot New Opioid CostsPharmaceutical industry critics say the new types of drugs the companies are pushing to address the nation's ongoing opioid crisis boost profits while forcing taxpayers to shoulder the costs.
Federal Reserve Chair Yellen Likely To Face Questions About Wells FargoThe nation's second largest bank engaged in practices that allegedly allowed the bank to open millions of accounts without customers' permission.
Mylan CEO Infuriates Lawmakers At Hearing On EpiPen CostsMylan CEO Heather Bresch infuriated lawmakers as she tried to explain steep cost increases of her company's life-saving EpiPens.